Updated: May 19, 2026

Alan E Smith

CADLCandel Therapeutics, Inc.SEC CIK: 0001021037
Estimated Net Worth
$27.7 Million
Last Updated: May 19, 2026 03:25 AM EST

Transaction Summary

Total Transactions48
Buy-Sell Ratio0.24
Buy Transactions8
Sell Transactions33

Transaction Volume

Total Volume$50.78M
Net Volume-$48M
Buy Volume$1.39M
Sell Volume$49.39M

Trade Analysis

AVG Trade Size$1.06M
Largest Trade$24.4M
Most Active MonthJul
Most Active Year2003

Trading Sentiment

OverallBearish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading chart

Monthly Trading Pattern

Loading chart

Past Insider Trading and Trends

Alan E Smith has an estimated net worth of $27.7 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, and Candel Therapeutics, Inc..



2003 was Alan E Smith's most active year for acquiring shares with 26 total transactions. Alan E Smith's most active month to acquire stocks was the month of May. 2003 was Alan E Smith's most active year for disposing of shares, totalling 36 transactions. Alan E Smith's most active month to dispose stocks was the month of May. 2008 saw Alan E Smith paying a total of $3,428,679.58 for 185,980 shares, this is the most they've acquired in one year. In 2008 Alan E Smith cashed out on 252,619 shares for a total of $10,452,096.07, their largest year based on trade value.

Holdings & Transactions

Loading…
Loading…